Skip to main content
. Author manuscript; available in PMC: 2010 May 1.
Published in final edited form as: J Immunol. 2009 May 1;182(9):5547–5559. doi: 10.4049/jimmunol.0802077

Table I.

Cell subsets important in mediating the effects of LPS on the establishment if hematopoietic chimerism in mice treated with costimulation blockadea

Group Host LPS Anti-NK Anti-CD8 Anti-CD4 Chimerism Frequency Donor-Origin PBMCs at 8 wk (%) MST of Skin Grafts in Transplanted Mice (days) MST of Skin Grafts in Nonchimeric Mice (days) MST of Skin Grafts in Chimeric Mice (days)
1 C57BL/6 No No No No 29/45 (64%) 1.59 ± 1.81 144 88 >260
2 C57BL/6 Yes No No No 0/23 (0%)b <0.10 11* 11 N/A
3 C57BL/6 No Yes No No 11/13 (84.6%) 2.45 ± 1.16 >221 72 >221
4 C57BL/6 Yes Yes No No 0/5 (<0.10%)c <0.10 12** 12 N/A
5 C57BL/6 No No Yes No 15/17 (88.2%) 0.90 ± 1.13 144 72.5 148
6 C57BL/6 Yes No Yes No 0/16 (<0.10%)d <0.10 44# 44 N/A
7 C57BL/6 No Yes Yes No 7/8 (87.5%) 3.67 ± 1.23 81 23 81
8 C57BL/6 Yes Yes Yes No 0/9 (<0.10%)e <0.10 28## 28 N/A
9 C57BL/6 No No No Yes 1/12 (8.33%) 0.58 46 37 >147
10 C57BL/6 Yes No No Yes 0/12 (<0.10%)f <0.10 18 18 N/A
11 C57BL/6 No No Yes Yes 4/4 (100%) 2.42 ± 0.55 >228 N/A >228
12 C57BL/6 Yes No Yes Yes 4/4 (100%)g 1.14 ± 0.35 228 N/A 228
13 CD8α−/− No No No No 12/17 (70.5%) 2.29 ± 1.76 96 51 136
14 CD8α−/− Yes No No No 0/17 (<0.10%)h <0.10 21$ 21 N/A
a

All mice were treated with a BALB/c DST and anti-CD154 mAb and transplanted with BALB/c bone marrow and skin according to our standard protocol without or with injection of 100 µg of LPS. Groups 3, 4, 7, and 8 were also given an injection of anti-NK1.1 mAb i.p on day −10 relative to bone marrow and skin transplantation. Groups 5, 6, 7, 8, 11, and 12 were given three doses of 0.5 mg of anti-CD8 mAb i.p. on days −10, −9, and −8 relative to bone marrow and skin transplantation. Groups 9, 10, 11, and 12 were given three doses of 0.5 mg of anti-CD4 mAb i.p. on days −10, −9, and −8 relative to bone marrow and skin transplantation. Hematopoietic chimerism was defined as >0.10% donor origin PBMCs 8 wk after bone marrow injection. The percentage of donor origin PBMCs is the mean ± SD percentage of the levels observed in chimeric mice. For groups with no chimeric mice, we used the limit of detection (<0.10) to indicate a lack of chimerism.

b

p = 0.017 vs group 1

c

p = 0.0005 vs group 3

d

p < 0.0001 vs group 5

e

p = 0.0003 vs group 7

f

p = NS vs group 9

g

p = NS vs group 11

h

p < 0.0001 vs group 13 by χ2 analysis.

*

p < 0.001 vs group 1

**

p < 0.0001 vs group 3

#

p < 0.0001 vs group 5

##

p < 0.01 vs group 7

$

p < 0.001 vs group 13 by log-rank analysis.

N/A, Not applicable.